State-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases
Harvard Infectious Diseases in Adults 2025 provides important updates and state-of-the-art approaches for the prevention, diagnosis, and management of infectious diseases: common, challenging, rare, and emerging. This highly rated course focuses on major clinical syndromes as well as management advances and controversies. It features a range of case-based, interactive problem-solving sessions from master clinicians in the field. Workshop panels bring together clinicians from the many disciplines who collaborate in the care of our patients. These include surgeons, radiologists, infectious disease pharmacists, pulmonologists, allergists, and microbiologists. This course is designed to provide learners with conceptual frameworks while reviewing the ways in which new developments impact those frameworks. Topics with major impact on clinical practice are emphasized, including infections of national and international importance and emerging infections. The 2025 program provides updates on vaccines, respiratory viral infections, the COVID-19 pandemic, mpox, and vector-borne diseases, and adds coverage on highly pathogenic avian influenza, Marburg virus, and critical care ID.
* Date of the original release: April 28 – May 2, 2025
LEARNING OBJECTIVES Upon completion of this course, participants will be better able to:
HARVARD INFECTIOUS DISEASE IN ADULTS 2025
